BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 21945313)

  • 21. Aggressive Intrinsic Subtypes in Breast Cancer: A Predictor of Guideline Adherence in Older Patients With Breast Cancer?
    Ebner F; Hancke K; Blettner M; Schwentner L; Wöckel A; Kreienberg R; Janni W; van Ewijk R
    Clin Breast Cancer; 2015 Aug; 15(4):e189-95. PubMed ID: 25913904
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognosis of bilateral synchronous breast cancer in Vaud, Switzerland.
    Levi F; Randimbison L; Te VC; La Vecchia C
    Breast; 2003 Apr; 12(2):89-91. PubMed ID: 14659336
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic impact of tumour-specific HMG-CoA reductase expression in primary breast cancer.
    Borgquist S; Jögi A; Pontén F; Rydén L; Brennan DJ; Jirström K
    Breast Cancer Res; 2008; 10(5):R79. PubMed ID: 18808688
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High estrogen receptor expression in early breast cancer: chemotherapy needed to improve RFS?
    Regierer AC; Wolters R; Kurzeder C; Wöckel A; Novopashenny I; Possinger K; Wischnewsky MB; Kreienberg R
    Breast Cancer Res Treat; 2011 Jul; 128(1):273-81. PubMed ID: 21210206
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The prognosis of bilateral breast carcinoma compared to unilateral breast tumor. 5- and 10-year follow-ups].
    Mose S; Adamietz IA; Thilmann C; Saran F; Pahnke R; Böttcher HD
    Strahlenther Onkol; 1995 Apr; 171(4):207-13. PubMed ID: 7740408
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Highly significant improvement in guideline adherence, relapse-free and overall survival in breast cancer patients when treated at certified breast cancer centres: An evaluation of 8323 patients.
    Kreienberg R; Wöckel A; Wischnewsky M
    Breast; 2018 Aug; 40():54-59. PubMed ID: 29698925
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Guidelines are advantageous, though not essential for improved survival among breast cancer patients.
    Wolters R; Wischhusen J; Stüber T; Weiss CR; Krockberger M; Bartmann C; Blettner M; Janni W; Kreienberg R; Schwentner L; Novopashenny I; Wischnewsky M; Wöckel A; Diessner J
    Breast Cancer Res Treat; 2015 Jul; 152(2):357-66. PubMed ID: 26105798
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comorbidity-dependent adherence to guidelines and survival in breast cancer-Is there a role for guideline adherence in comorbid breast cancer patients? A retrospective cohort study with 2137 patients.
    Wollschläger D; Meng X; Wöckel A; Janni W; Kreienberg R; Blettner M; Schwentner L
    Breast J; 2018 Mar; 24(2):120-127. PubMed ID: 28685896
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic value of breast cancer subtypes on breast cancer specific survival, distant metastases and local relapse rates in conservatively managed early stage breast cancer: a retrospective clinical study.
    Sanpaolo P; Barbieri V; Genovesi D
    Eur J Surg Oncol; 2011 Oct; 37(10):876-82. PubMed ID: 21824742
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Postoperative adjuvant chemotherapy followed by adjuvant tamoxifen versus nil for patients with operable breast cancer: a randomised phase III trial of the European Organisation for Research and Treatment of Cancer Breast Group.
    Morales L; Canney P; Dyczka J; Rutgers E; Coleman R; Cufer T; Welnicka-Jaskiewicz M; Nortier J; Bogaerts J; Therasse P; Paridaens R; ;
    Eur J Cancer; 2007 Jan; 43(2):331-40. PubMed ID: 17134892
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognosis of early-stage synchronous bilateral invasive breast cancer.
    Schmid SM; Pfefferkorn C; Myrick ME; Viehl CT; Obermann E; Schötzau A; Güth U
    Eur J Surg Oncol; 2011 Jul; 37(7):623-8. PubMed ID: 21628090
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bilateral breast cancers in an Asian population, and a comparison between synchronous and metachronous tumours.
    Sim Y; Tan VKM; Sidek NAB; Chia DKA; Tan BKT; Madhukumar P; Yong WS; Wong CY; Ong KW
    ANZ J Surg; 2018 Oct; 88(10):982-987. PubMed ID: 30141242
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bilateral breast carcinoma: risk factors and outcomes for patients with synchronous and metachronous disease.
    Heron DE; Komarnicky LT; Hyslop T; Schwartz GF; Mansfield CM
    Cancer; 2000 Jun; 88(12):2739-50. PubMed ID: 10870056
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tree-based model for breast cancer prognostication.
    Banerjee M; George J; Song EY; Roy A; Hryniuk W
    J Clin Oncol; 2004 Jul; 22(13):2567-75. PubMed ID: 15226324
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A Retrospective Study on the Clinicopathologic Characteristics and Outcomes of 179 Cases of Synchronous and Metachronous Bilateral Breast Cancer in China.
    Jia H; Zheng Y; Wang P; Wei Z; Li X; Fu G; Wang C
    Clin Breast Cancer; 2022 Apr; 22(3):e341-e349. PubMed ID: 34728164
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bilateral breast carcinoma: clinical characteristics and its impact on survival.
    Vuoto HD; García AM; Candás GB; Zimmermann AG; Uriburu JL; Isetta JA; Cogorno L; Khoury M; Bernabó OL
    Breast J; 2010; 16(6):625-32. PubMed ID: 21070440
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of quality of treatment on prognosis in primary breast cancer patients treated in daily practice.
    Ottevanger PB; De Mulder PH; Grol RP; Van Lier H; Beex LV
    Anticancer Res; 2002; 22(1A):459-65. PubMed ID: 12017333
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adherence to guidelines and benefit of adjuvant radiotherapy in patients with invasive breast cancer: results from a large population-based cohort study of a cancer registry.
    Wimmer T; Ortmann O; Gerken M; Klinkhammer-Schalke M; Koelbl O; Inwald EC
    Arch Gynecol Obstet; 2019 Apr; 299(4):1131-1140. PubMed ID: 30607594
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Endocrine therapy in obese patients with primary breast cancer: another piece of evidence in an unfinished puzzle.
    Wolters R; Schwentner L; Regierer A; Wischnewsky M; Kreienberg R; Wöckel A
    Breast Cancer Res Treat; 2012 Feb; 131(3):925-31. PubMed ID: 22080246
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ascertaining prognosis for breast cancer in node-negative patients with innovative survival analysis.
    Chapman JA; Lickley HL; Trudeau ME; Hanna WM; Kahn HJ; Murray D; Sawka CA; Mobbs BG; McCready DR; Pritchard KI
    Breast J; 2006; 12(1):37-47. PubMed ID: 16409585
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.